Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

GSK plc (GSK.L) News - StockMarketCap

Stocks›GSK plc☆

● At closeAs of Jul 2, 2026

GSK plc

LON: GSK✓

HealthcareDrug Manufacturers - GeneralLSE

$26.75£20.04+3.83%

$107.19BMarket cap

13.66xP/E ratio

17.57MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$26.75£20.04

$0.99 (+3.83%) · 24h

Key metrics

Market cap$107.19B+7.52%

Enterprise value$126.83B

Volume (24h)17.57M

P/E ratio (TTM)13.66x

P/S ratio (TTM)2.42x

Dividend yield3.38%

Shares outstanding40.07M

Trading range

Previous close£19.30

Day range£19.43 - £20.13

52-week range£12.89 - £22.82

GSK plc (GSK.L) operates in the Drug Manufacturers - General industry within the Healthcare sector, listed on LSE.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news